Explore Your Local Site

Looks like you've landed on our   site. Let's take you home:    

Please note that the content and products on the    site might not be available in your region.

 

Choose the language:

  Homepage
Continue on the current website:  

 

Calantic AI Visions | Part 1: Recognizing the Challenges

Calantic AI Visions | Part 1: Recognizing the Challenges

2024-03-27

In the first section of the AI Visions event, the panel discusses the main challenges facing radiology today and what could...

Radiology
Academy

Medical Education
On Demand

Request a Meeting

Calantic AI Visions | Part 1: Recognizing the Challenges

Video title from video component

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Tags

  • #Scalability of AI

Duration

20m 16s

About this Video

In the first section of the AI Visions event, the panel discusses the main challenges facing radiology today and what they potentially could be tomorrow. One specific topic is how AI could help to meet these challenges and how radiologists and healthcare institutions can overcome barriers such as scalability, access to funding, and reliability.

Speakers

Subrata Bose photo

YYMMDD

Subrata Bose PhD, MBA, MSc, BPharma
Vice President, Diagnostic Imaging, Data & Artificial Intelligence, Head General Clinical Imaging Services at Bayer Ag | MIT | Durham | Imperial

Dr. Christina Biermann photo

YYMMDD

Dr. Christina Biermann
Head of Application Development & Integration, Bayer Pharmaceuticals

Joana Reis photo

YYMMDD

Joana Reis, MD, PhD
Global Medical Affairs Senior Manager for Digital Radiology @Bayer, Senior Consultant Radiologist

References
  1. Cuocolo et al. Eur J Nuc Med Mol Imaging 2010
  2. Boellaard et al, 2015, Eur J Nucl Med Mol Imaging
  3. Antoch et al. JNM 2004
  4. Behrendt et al Eur Rad 2012
  5. Flavell et al. Acad Rad 2014
LinkedIn LinkedIn

© 2022, 2023 Bayer

The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

BAYER, the Bayer Cross, Radimetrics and Calantic are trademarks owned by Bayer and/or registered in the U.S. Other trademarks and company names mentioned herein are properties of their respective owners.

This is intended to provide information for healthcare professionals and other relevant decision makers in the US. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

 

Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information.

 

You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

 

Bayer U.S. | Digital Solutions, 100 Bayer Blvd., Whippany, NJ 07981-0915

 

Last Updated: September 2023

© 2022, 2023, 2024 Bayer

The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

BAYER, the Bayer Cross, Radimetrics and Calantic are trademarks owned by Bayer and/or registered in the U.S. Other trademarks and company names mentioned herein are properties of their respective owners.

This is intended to provide information for healthcare professionals and other relevant decision makers in the US. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

 

Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information.

 

You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

 

Bayer U.S. | Digital Solutions, 100 Bayer Blvd., Whippany, NJ 07981-0915

 

Last Updated: October 2024

Bayer Logo
  • United States